AIRWAYS ICPs (Action Plan B3, EIP on AHA) develops multisectoral care pathways (ICPs) for rhinitis and its multimorbidities, implementing emerging technologies for individualised and predictive medicine using an ICT tool available in 15 EU countries and already tested in 5,000 users of all ages. This smartphone-based tool allows the assessment of rhinitis control and uses a clinical decision support system.
1- MASK (MACVIA-ARIA Sentinel network) ALLERGY DIARY: MASK-rhinitis is a simple ICT tool to implement care pathways for allergic rhinitis from patients to health care providers using a common language for patients, health care providers and social carers. This is based on the assessment of the control of allergic rhinitis by a visual analogue scale on and App and a tablet. MASK-rhinitis will allow (i) the patients to screen for allergic disease, (ii) the pharmacists, to guide them in the prescription of OTC medications and direct the uncontrolled patients to physicians, (iii) the primary care physician, to prescribe appropriate treatment and to follow-up with the patient according to the physician’s instructions (CDSS) and assessment of control, (iv) the specialist and outpatient clinics in allergology, if there is failure to gain control by the primary physician and (v) assess work productivity. Moreover, EQ-5D is included in the tool allowing MAFEIP. MASK-rhinitis is important for establishing care pathways across the life cycle, stratify patients with severe uncontrolled rhinitis and to perform clinical trials.
3- CLINICAL DECISION SUPPORT SYSTEM: The selection of pharmacotherapy for patients with allergic rhinitis depends on several factors, including age, prominent symptoms, symptom severity, control of allergic rhinitis, patient preferences and cost. Allergen exposure and resulting symptoms vary and treatment adjustment is required. Clinical decision support systems (CDSS) are beneficial for the assessment of disease control if based on the best evidence and algorithms to aid patients and health care professionals to jointly determine the treatment and its step-up or step-down strategy depending on AR control. MASK Allergy Diary will include a CDSS (End 2016) with an algorithm developed by consensus (Bousquet J et al, J Allergy Clin Immunol, 2016, in press).
The tool belongs to the Région Occitanie (France)